05/21/2007
Federal Register Notice: FDA has determined the regulatory review period for Schering Corp.’s Noxafil (posaconazole) is 3,65...05/21/2007
Federal Register Notice: FDA has determined the regulatory review period for AstraZeneca’s Iressa is 1,967 days for extendin...05/21/2007
Federal Register Notice: FDA has determined the regulatory review period for Guidant Corp.’s Galileo Intravascular Radiother...05/21/2007
Federal Register Notice: FDA is releasing “Modifications to the List of Recognized Standards, Recognition List Number: 017&r...05/14/2007
Federal Register Notice: FDA is seeking public comment on the collection of information contained in the guidance Information Prog...11/27/2006
Federal Register Notice: FDA is making available a document entitled Guidance for Industry, FDA Staff, Eye Care Professionals, an...11/27/2006
Federal Register Notice: FDA’s Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee will meet...11/08/2006
Federal Register Notice: FDA is seeking comments on extending Office of Management and Budget (OMB) approval on the existing repo...